Global Assistive Reproductive Technology Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Assistive Reproductive Technology Market Research Report 2024
Assisted reproductive technology (ART) are the medical procedures used for infertility treatment, in which eggs are surgically removed from the ovaries and are combined with the sperms in a laboratory.
According to MRAResearch’s new survey, global Assistive Reproductive Technology market is projected to reach US$ 38130 million in 2033, increasing from US$ 28150 million in 2022, with the CAGR of 4.6% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Assistive Reproductive Technology market research.
The Assisted Reproductive Technology (ART) market is primarily driven by the increasing demand for fertility treatments and solutions to overcome infertility challenges. ART encompasses a range of medical procedures and technologies that aid individuals and couples in achieving pregnancy. The growing prevalence of infertility due to various factors such as age, lifestyle, and medical conditions, coupled with advancements in reproductive medicine and technology, contributes to market growth. Moreover, the demonstrated success of ART methods such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) in helping couples conceive further propels adoption. However, challenges include addressing ethical considerations, optimizing treatment protocols, and managing the emotional and psychological aspects of fertility treatments. Navigating legal regulations, ensuring affordability and accessibility, and providing comprehensive patient support are ongoing concerns. The market's success relies on continuous research in reproductive health, collaborations between fertility clinics and medical manufacturers, and comprehensive patient education on the benefits and potential challenges of using ART while addressing the evolving challenges associated with infertility treatment and family planning.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Assistive Reproductive Technology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Cooper Surgical
Hamilton Thorne
FUJIFILM Irvine Scientific
Nidacon International
Vitrolife AB
Merck
INVO Bioscience
IVFtech
Gonagen Medikal
Cook Medical
CellCura
Segment by Type
In-vitro fertilization (IVF)
Artificial Insemination-Intrauterine Insemination (AI-IUI)
Frozen Embryo Replacement (FER)
Other
Fertility Clinics
IVF Center
Hospital
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Assistive Reproductive Technology report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Assistive Reproductive Technology market is projected to reach US$ 38130 million in 2033, increasing from US$ 28150 million in 2022, with the CAGR of 4.6% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Assistive Reproductive Technology market research.
The Assisted Reproductive Technology (ART) market is primarily driven by the increasing demand for fertility treatments and solutions to overcome infertility challenges. ART encompasses a range of medical procedures and technologies that aid individuals and couples in achieving pregnancy. The growing prevalence of infertility due to various factors such as age, lifestyle, and medical conditions, coupled with advancements in reproductive medicine and technology, contributes to market growth. Moreover, the demonstrated success of ART methods such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) in helping couples conceive further propels adoption. However, challenges include addressing ethical considerations, optimizing treatment protocols, and managing the emotional and psychological aspects of fertility treatments. Navigating legal regulations, ensuring affordability and accessibility, and providing comprehensive patient support are ongoing concerns. The market's success relies on continuous research in reproductive health, collaborations between fertility clinics and medical manufacturers, and comprehensive patient education on the benefits and potential challenges of using ART while addressing the evolving challenges associated with infertility treatment and family planning.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Assistive Reproductive Technology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Cooper Surgical
Hamilton Thorne
FUJIFILM Irvine Scientific
Nidacon International
Vitrolife AB
Merck
INVO Bioscience
IVFtech
Gonagen Medikal
Cook Medical
CellCura
Segment by Type
In-vitro fertilization (IVF)
Artificial Insemination-Intrauterine Insemination (AI-IUI)
Frozen Embryo Replacement (FER)
Other
Segment by Application
Fertility Clinics
IVF Center
Hospital
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Assistive Reproductive Technology report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source